Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT04129944

Public ClinicalTrials.gov record NCT04129944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study of UBX0101 in Moderate to Severe, Painful Osteoarthritis of the Knee

Study identification

NCT ID
NCT04129944
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Unity Biotechnology, Inc.
Industry
Enrollment
183 participants

Conditions and interventions

Interventions

  • UBX0101 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 29, 2019
Primary completion
May 19, 2020
Completion
Aug 6, 2020
Last update posted
Dec 28, 2021

2019 – 2020

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Central Research Associates Birmingham Alabama 35205
Coastal Clinical Research, LLC. Mobile Alabama 36608
Fiel Family and Sports Medicine Tempe Arizona 85283
Tucson Orthopaedic Institute Tucson Arizona 85712
Biosolutions Clinical Research Center La Mesa California 91942
Diablo Clinical Research Walnut Creek California 94598
Charter Research Lady Lake Florida 32159
Well-Pharma Medical Research Miami Florida 33143
Precision Clinical Research Sunrise Florida 33351
Premier Medical Associates The Villages Florida 32159
Chicago Clinical Research Institute Chicago Illinois 60607
The Alliance for Multispecialty Research Wichita Kansas 67207
Alliance for Multispecialty Research-Lexington Lexington Kentucky 40509
The Alliance for Multispecialty Research Kansas City Missouri 64114
Hassman Research Institute Berlin New Jersey 08009
Albuquerque Clinical Trials Albuquerque New Mexico 87102
Drug Trials America Hartsdale New York 10530
Rochester Clinical Research Rochester New York 14609
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Coastal Carolina Research Center North Charleston South Carolina 29406

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04129944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 28, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04129944 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →